A Prognostic Nomogram Predicts Survival in Recurrent Ovarian Cancer Treated With Bevacizumab and Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Gynecologic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Prognostic Nomogram to Predict Overall Survival in Women With Recurrent Ovarian Cancer Treated With Bevacizumab and Chemotherapy
Gynecol. Oncol 2014 Jan 25;[EPub Ahead of Print], R Previs, K Bevis, W Huh, T Tillmanns, L Perry, K Moore, J Chapman, C McClung, T Kiet, J Java, J Chan, AA SecordFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.